Certain FDAMA Provisions Underutilized By Device Firms, Hill Aide Says

Manufacturers should be more aggressive in pressing for their rights under the FDA Modernization Act, Senate Labor and Human Resources Health Policy Advisor Jay Hawkins told the Regulatory Affairs Professionals Society Oct. 28 in Washington, D.C.

More from Archive

More from Medtech Insight